Plant active metabolites: A new paradigm in the treatment of Hypertension (a brief description of Indian Pharmacopoeia – 2022 herbal monographs)

Hypertension is a significant public health problem worldwide. Nearly two-thirds of all hypertensive patients live in developing and under-developed countries, creating considerable burden hypertension. India among the countries which spend more than one-third income on cardiovascular diseases Although several modern medications are available to control disease symptoms, their expense side effects restrict use. More 80% world's population relies traditional treatment, used recklessly without any restrictions or proof thereof. Indian Pharmacopoeia working diligently towards standardising herbal drugs plant-derived pharmaceuticals, i.e., Phyto-pharmaceuticals, regulate usage. The present article focuses standardisation marker compounds different indigenous anti-hypertensive medicinal plants, can be as bioactive markers phytopharmaceutical drug development. study includes consolidated information about important biomarkers identification assay methodology.